Eppendorf and BioLabs expand collaboration to support biotech innovation in Munich
The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies
23 Oct 2026
From left to right: Dr. Johannes Fruehauf, CEO BioLabs, Dr. Max Pöhlmann, Site Director, BioLabs TUM, Dr. Floris Engelhardt, CEO/CSO & Co-Founder Kano Therapeutics, Dr. Philipp Gerbert, CEO TUM Venture Labs, Johanna Michielin, Regional Director, BioLabs Europe
Eppendorf and BioLabs have announced the expansion of their collaboration to BioLabs’ new Munich site, BioLabs | TUM, extending a relationship that already includes BioLabs locations in the U.S, France and Germany. The partnership will provide biotech and life-science entrepreneurs with access to laboratory equipment, technical expertise and a connected innovation community.
Under the partnership, Eppendorf will participate as a Gold Sponsor of BioLabs | TUM. The collaboration reflects a shared commitment to strengthening the life-science ecosystem. BioLabs provides the space, community, and operational environment in which startups can develop, while Eppendorf contributes laboratory technologies and expertise that support day-to-day research and growth. This includes providing instrumentation and related software, staff training programs, and equipment maintenance, as well as delivering lectures and conferences.
The site will provide opportunities for workshops, office hours, on-site events and other engagement activities for BioLabs’ resident companies.
The BioLabs | TUM site provides shared and private laboratory spaces, offices, operational support, and access to a community of entrepreneurs, mentors, investors, and industry partners.
“Expanding our collaboration with BioLabs to the new Munich site allows us to bring Eppendorf’s equipment and expertise closer to a new generation of biotech companies,” said Axel Ziemke, Vice President Central Area EMEA, Eppendorf Vertrieb Deutschland GmbH.
“The partnership combines practical support for laboratories with opportunities for direct exchange between Eppendorf and the companies shaping the future of life science.”
Johannes Fruehauf, CEO and Founder of BioLabs, added, “BioLabs’ partnership with Eppendorf spans more than a decade, and we are very proud to extend this long-standing collaboration to Munich. Our mission is to support entrepreneurs and innovative scientists as they bring breakthrough ideas to life, and we are confident that Eppendorf shares that commitment. We are excited to have Eppendorf join us in supporting the next generation of life-science companies in Munich and look forward to building on our collaboration in this important ecosystem.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Links
Tags
Frequently asked questions
Show frequently asked questions
How will the Eppendorf and BioLabs partnership support biotech startups in Munich?
As a Gold Sponsor of BioLabs | TUM, Eppendorf will provide laboratory instrumentation and software, technical expertise, staff training, equipment maintenance, lectures and conferences. Resident biotech and life science companies will also benefit from workshops, office hours and onsite events.
What facilities and resources does BioLabs | TUM offer life-science entrepreneurs?
BioLabs | TUM provides shared and private laboratory spaces, offices and operational support. Located in Munich’s innovation ecosystem and connected with TUM Venture Labs, it also gives resident companies access to entrepreneurs, mentors, investors and industry partners.
Where else do Eppendorf and BioLabs collaborate?
The expanded partnership at BioLabs | TUM builds on a relationship spanning more than a decade. Eppendorf and BioLabs already collaborate at BioLabs locations in the United States, France and Germany, supporting life science discovery and biotech innovation.